mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.2 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.2 |
mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.2 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |